[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2024; 8: (10) ; 10.12208/j.ijcr.20240445 .

Clinical clinical effect of tumor treatment in traditional Chinese medicine
中医治疗肿瘤方法初探之扶正散法临床疗效

作者: 雷贵仙1 *, 雷峥2

1 江西省井冈山市柏露乡上坊村卫生所 江西井冈山

2 江西吉安市吉安慈济二院 江西吉安

*通讯作者: 雷贵仙,单位: 江西省井冈山市柏露乡上坊村卫生所 江西井冈山;

引用本文: 雷贵仙, 雷峥 中医治疗肿瘤方法初探之扶正散法临床疗效[J]. 国际临床研究杂志, 2024; 8: (10) : 187-189.
Published: 2024/10/29 16:41:28

摘要

目的 本文旨在分析中医扶正散法治疗肿瘤的方法及临床疗效。方法 本次研究取2023年1月-2024年1月我院肿瘤患者30例作为研究对象,根据临床治疗方式的区别将患者分两组,常规西医治疗者共15例拟为参照组,在常规治疗基础上配合中医治疗者(扶正散)15例拟为研究组,观察两组临床疗效,统计两组治疗有效率、不良反应、肿瘤标志物水平、生活质量评分。结果 本次研究显示,治疗有效率研究组高于参照组(P<0.05);患者不良反应情况,可见研究组低于参照组(P<0.05);两组患者CEA、CA19-9、CA724、AFP、TSGF各项肿瘤标志物水平治疗后研究组低于参照组(P<0.05);患者社会功能、躯体功能、生理功能、心理功能各项生活质量评分数据研究组高于参照组(P<0.05)。结论 经过对比分析,中医扶正散的应用,可全面提升肿瘤患者的临床疗效,降低不良反应出现,并且降低肿瘤标志物水平,促使患者生活质量提升,并获得患者满意,临床效果理想,具备推广价值。

关键词: 中医;扶正散;肿瘤;临床疗效

Abstract

Objective This paper aims to analyze the treatment methods and clinical efficacy of traditional Chinese medicine.
Methods This study in January 2023-January 2024 our hospital 30 tumor patients as a research object, according to the difference between clinical treatment of patients are divided into two groups, conventional western medicine treatment a total of 15 cases to reference group, on the basis of conventional treatment with Chinese medicine treatment (scattered) 15 cases to study group, observe two groups of clinical curative effect, statistical two groups of treatment efficiency, adverse reactions, tumor marker level, quality of life score.
Results This study showed that the study group was higher than the reference group (P <0.05); the patients had adverse effects, so the study group was lower than the reference group (P <0.05); the study group of CEA, CA19-9, CA724, AFP, TSGF after treatment was lower than the reference group (P <0.05); the study group of social function, physical function, physiological function and psychological function were higher than the reference group (P <0.05).
Conclusion   After comparative analysis, the application of traditional Chinese medicine can comprehensively improve the clinical efficacy of cancer patients, reduce the occurrence of adverse reactions, reduce the level of tumor markers, promote the quality of life of patients, and obtain the satisfaction of patients, and the clinical effect is ideal, has the promotion value.

Key words: Traditional Chinese medicine; Healthy powder; Tumor; Clinical efficacy

参考文献 References

[1] 孙秀凤,周芬,吴婷. 扶正散结合剂联合厄洛替尼在晚期非小细胞肺癌患者中的临床效果及对肿瘤标志物的影响研究[J]. 世界中西医结合杂志,2021,16(1):104-107. 

[2] 胡嘉芮,何晓华,王永霞,等. 解毒散结扶正法辅助化疗对老年晚期膀胱癌患者机体免疫状态和肿瘤转移侵袭的影响[J]. 湖南师范大学学报(医学版),2021,18(3):73-77. 

[3] 李振前,盛丹丹,刘戎惠,等. 扶正散瘀方结合SOX化疗方案在提高胃癌患者免疫力及对肿瘤标志物影响的研究[J]. 辽宁中医杂志,2023,50(11):81-84. 

[4] 刘抒玉,张征宇. 扶正散结合剂联合化疗对胃癌患者中医证候、肿瘤标志物及免疫功能的影响[J]. 河北中医,2020,42(3):402-406. 

[5] 单京瑞,刘雅静,徐曼,等. 扶正散结方对肺腺癌Bax、Bcl-2表达及肿瘤生长的影响[J]. 临床医学进展,2024,14(5):178-186. 

[6] 刘康,范小宇,彭力. 基于TGF-β1/Smad信号通路探讨扶正解毒散结方对原发性肝癌患者细胞免疫状态、肿瘤微环境的影响[J]. 中国中西医结合消化杂志,2021,29(5):330-335,341.

[7] 吴慧婷,吴春红,王利勤,等. 温阳散结治疗恶性肿瘤的研究进展[J]. 中国中医药现代远程教育,2024,22(9):166-168.  韩佳彤,田菲,林方圆,等. 扶正散结方联合顺铂对腹水瘤小鼠免疫调节作用的研究[J]. 天津中医药大学学报,2023,42(3):334-338.